Cardiovascular & Thoracic Surgery News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Should an emergency physician be a "surgeon" in a rural area? A case of blunt cardiac rupture successfully treated by an emergency physician - Kubo K, Abe T, Nagoshi H, Ochiai H.
We report a case of blunt cardiac rupture in a rural area in which emergency physicians performed emergency department thoraco... (Source: SafetyLit)
Source: SafetyLit - April 26, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Too Ill for Typical Transplants, Woman Gets a Pig Kidney and Heart Pump Instead
(MedPage Today) -- A 54-year-old New Jersey woman has become the first-ever patient to undergo combined mechanical heart pump and gene-edited pig kidney transplant surgery, doctors announced. The patient, Lisa Pisano, had heart failure and end... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 25, 2024 Category: Cardiology Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with abouthalf of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2TheNational Comprehensive Cancer Network ® (NCCN®)Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selectionBasel, 19 April 2024 - Roche (SIX: RO,...
Source: Roche Investor Update - April 19, 2024 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with abouthalf of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2TheNational Comprehensive Cancer Network ® (NCCN®)Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selectionBasel, 19 April 2024 - Roche (SIX: RO,...
Source: Roche Media News - April 19, 2024 Category: Pharmaceuticals Source Type: news

How to Talk to Your Family About Their Heart Health History
Hypertrophic obstructive cardiomyopathy (HOCM) is the most common genetic heart disease, affecting about 1 in every 500 people, according to the American Heart Association (AHA). In people with HOCM, genetic variants cause the heart’s walls to thicken and stiffen, blocking blood from flowing freely from the left ventricle to the aorta. This, in turn, results in shortness of breath and chest pain (especially during physical activity), abnormal heart rhythms, lightheadedness, dizziness, and fainting, and can worsen over time. [time-brightcove not-tgx=”true”] If a parent has HOCM, offspring have a 50% ch...
Source: TIME: Health - April 11, 2024 Category: Consumer Health News Authors: Sarah Klein Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

CT-FFR reduces invasive procedures for coronary artery blockages
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found. A team led by Mangun Kaur Randhawa, MD, of Massachusetts General Hospital in Boston reported that individuals with significant narrowing and/or blockages identified on coronary CT angiography (CTA) who underwent CT-FFR had lower rates of invasive coronary angiography and ensuing percutaneous coronary intervention than patients who were not referred for a CT-FFR. The research was published A...
Source: AuntMinnie.com Headlines - April 11, 2024 Category: Radiology Authors: Kate Madden Yee Tags: CT Cardiovascular Radiology Source Type: news

What Treatment Reduces Cardiac Risk in Hyperthyroidism? What Treatment Reduces Cardiac Risk in Hyperthyroidism?
Patients with hyperthyroidism had a lower risk for deadly cardiovascular events after surgery or radioactive iodine than those with ATDs, found a national cohort study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

AI model predicts invasiveness of lung cancer on CT scans
Radiologists in Beijing, China, have developed a joint deep learning and radiomics AI model that can flag how invasive tumors may be in patients with lung cancer, according to a study published April 9 in Radiology. The approach could ultimately help clinicians determine which patients with suspected disease are candidates for surgery, noted led authors Zhengsong Pan and Ge Hu, PhD, of Peking Union Medical College Hospital. “These models could assist in the preoperative care of patients with lung adenocarcinoma,” the group wrote. Lung adenocarcinoma is the most common primary lung cancer seen in the U.S. Tumors mani...
Source: AuntMinnie.com Headlines - April 9, 2024 Category: Radiology Authors: Will Morton Tags: CT Artificial Intelligence Thoracic Imaging Source Type: news

Can Chat GPT accurately refer patients to IR for treatment?
Chloe Cross, MD, of Icahn School of Medicine at Mount Sinai in New York City.In interventional radiology (IR), most of us quickly become accustomed to needing to explain what we do -- to other clinicians, patients, their families, and even our own families. But how do patients get their own information about IR, if at all? When a patient receives a diagnosis, they may have multiple medical specialists offering various treatment recommendations, so they may be unsure which to follow.If patients search for information using new tools like artificial intelligence, what is it telling them? How much does AI know about IR? Does ...
Source: AuntMinnie.com Headlines - April 1, 2024 Category: Radiology Authors: Chloe G. Cross, MD Tags: Interventional Interventional Radiology Source Type: news

How Hypertrophic Cardiomyopathy Progresses in Adults
Hypertrophic cardiomyopathy is the most common form of genetic heart disease worldwide. Researchers have estimated that up to 1 in 200 people have the condition, which is characterized by an abnormal thickening of the walls of the heart. This thickening can make it difficult for the heart to pump blood. Hypertrophic cardiomyopathy can be a deadly disease, and there was a time when it was largely untreatable. But the last 20 years have witnessed a sea change in the condition’s management—a change that has led to an estimated 10-fold decrease in deaths. [time-brightcove not-tgx=”true”] “...
Source: TIME: Health - March 27, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance healthscienceclimate Source Type: news

Siemens Healthineers' Ciartic Move gets FDA clearance
The U.S. Food and Drug Administration (FDA) has cleared Siemens Healthineers' Ciartic Move, a mobile C-arm with self-driving capabilities. The company said the system standardizes 2D fluoroscopic and 3D cone-beam CT imaging for surgeons and operating room teams in hospitals and outpatient facilities. Ciartic Move is designed to address the needs of orthopedic, trauma, and spine surgery. It can be used in thoracic, vascular, cardiovascular, and general surgery, as well as urology and interventional pulmonology.Ciartic Move. Image courtesy of Siemens Healthineers. The system is fully motorized from the C-arm down to its wh...
Source: AuntMinnie.com Headlines - March 21, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Biden Administration Finalizes Chrysotile Asbestos Ban
Joining 50 other countries that have already banned asbestos, the United States is now banning chrysotile asbestos. The Biden administration has officially finalized the ban that follows decades of calls from survivors of asbestos-related diseases, medical professionals, veterans and first responders. Chrysotile asbestos, also known as white asbestos, continues to be imported into the U.S., particularly for use in the chloralkali industry. Anticipating a ban, imports of asbestos rose dramatically in 2022 from 100 metric tons in all of 2021 to 114 metric tons in just the first 3 months of 2022, according to the U.S. Inte...
Source: Asbestos and Mesothelioma News - March 18, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Companies Legal Support/Support Groups/Organizations Source Type: news

The Most Exciting New Advances in Managing COPD
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National Institutes of Health and the World Health Organization, one of GOLD’s stated aims is to “improve prevention and treatment of this lung disease.” In its 2023 global strategy report, GOLD changed its definition of COPD—which many in the profession viewed as overdue. Specifically, the new definition emphasized the heterogeneity of COPD in terms of its underlying drivers and long-term disease course. [ti...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance Source Type: news